Holen Sie sich die Stockscreener-App
2.31
0.86%
-0.02
Handel nachbörslich:
2.31
Schlusskurs vom Vortag:
$2.33
Offen:
$2.4
24-Stunden-Volumen:
519.89K
Relative Volume:
0.51
Marktkapitalisierung:
$2.94M
Einnahmen:
$2.45M
Nettoeinkommen (Verlust:
$-5.47M
KGV:
-0.039
EPS:
-59.1634
Netto-Cashflow:
$-6.05M
1W Leistung:
+8.45%
1M Leistung:
+5.00%
6M Leistung:
-6.85%
1J Leistung:
-97.98%
1-Tages-Spanne:
$2.2286
$2.40
1-Wochen-Bereich:
$2.11
$2.40
52-Wochen-Spanne:
$0.6273
$119.98
Pmgc Holdings Inc Stock (ELAB) Company Profile
Firmenname
Pmgc Holdings Inc
Sektor
Branche
Telefon
888-445-4886
Adresse
120 NEWPORT CENTER DRIVE, NEWPORT BEACH
Vergleichen Sie ELAB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ELAB
Pmgc Holdings Inc
|
2.31 | 2.94M | 2.45M | -5.47M | -6.05M | -59.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.03 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
547.74 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
329.77 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
545.11 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
244.32 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Pmgc Holdings Inc Aktie (ELAB) Neueste Nachrichten
PMGC Capital Urges Alaunos Therapeutics to Accept Strategic Financing Opportunity - Nasdaq
PMGC Capital LLC Urges Alaunos Therapeutics (NASDAQ: TCRT) - GlobeNewswire
PMGC Capital LLC Urges Alaunos Therapeutics (NASDAQ: TCRT) to Accept Term Sheet from Leading - Bluefield Daily Telegraph
Clean Financing Deal: Top Wall Street Bank Backs Alaunos While Major Investor PMGC Capital Demands Action - Stock Titan
Northstrive Biosciences Announces Initiation of Phase II of - GlobeNewswire
Northstrive Biosciences Announces Initiation of Phase II of Collaboration to Develop AI Powered Therapies for Obesity and Cardiometabolic Diseases - Stock Titan
Daily Progress: PMGC Holdings Inc (ELAB) Drop -0.96, Closing at 2.06 - DWinneX
Market Recap: Next Technology Holding Inc (NXTT)’s Positive Momentum, Closing at 1.40 - DWinneX
PMGC signs LOI to acquire California-based CNC machining company By Investing.com - Investing.com South Africa
PMGC signs LOI to acquire California-based CNC machining company - Investing.com Australia
PMGC Holdings Inc. Enters Non-Binding LOI to Acquire California-Based CNC Machining Company Specializing in Aerospace and Defense - Nasdaq
TKO Group President Mark Shapiro Headlines JP Morgan Conference: Key Strategic Updates Expected - Stock Titan
PMGC Holdings Inc. Signs Letter of Intent to Acquire - GlobeNewswire
PMGC Holdings Inc. Signs Letter of Intent to Acquire Profitable U.S.-Based AS9100D & ISO 9001:2015 Certified CNC Machine Shop Serving Aerospace, Defense, and Industrial Markets for over 35 years - Yahoo Finance
PMGC Holdings Signs Letter of Intent to Acquire Profitable U.S.-Based Electronics Manufacturing Company - I-Connect007
PMGC Holdings to acquire U.S. electronics manufacturer By Investing.com - Investing.com South Africa
PMGC Plans to Acquire US-based Electronics Manufacturing Firm; Shares Rise - MarketScreener
PMGC Stock Rockets After Acquiring US Electronics Firm: Retail Ramps Up Exposure By Stocktwits - Investing.com India
PMGC Stock Rockets After Acquiring US Electronics Firm: Retail Ramps Up Exposure - Asianet Newsable
PMGC Holdings to acquire U.S. electronics manufacturer - Investing.com Australia
PMGC signs LOI to acquire electronics contract manufacturing company - TipRanks
PMGC Holdings Inc. Signs Letter of Intent to Acquire High-Precision Electronics Manufacturing Company - Nasdaq
PMGC Holdings Inc. Signs Letter of Intent to Acquire Profitable U.S.-Based Electronics Manufacturing Company - GlobeNewswire
PMGC Holdings Expands PCB Manufacturing Empire with Second Strategic Acquisition Since April - Stock Titan
Elevai Labs stock plunges to 52-week low of $2.09 amid steep decline By Investing.com - Investing.com South Africa
Elevai Labs stock plunges to 52-week low of $2.09 amid steep decline - Investing.com Australia
Northstrive Biosciences completes phase I research on muscle-wasting treatment - Investing.com
NorthStrive Biosciences Announces Completion of Phase I Strategic Review for EL-22 Targeting Muscle Loss Associated with GLP-1 Weight Loss Drugs and Age-Related Sarcopenia - GlobeNewswire
Northstrive Biosciences Amends License Agreement with MOA Life - TipRanks
PMGC Holdings Inc. Files Quarterly Report for Q1 2025, Highlights Strategic Growth Initiatives - Nasdaq
PMGC Holdings Inc. Announces Filing of Quarterly Report on Form 10-Q - The Manila Times
PMGC Holdings Expands into Hot GLP-1 Market While Pursuing Tech Acquisition: Q1 2025 Details Released - Stock Titan
PMGC Holdings Highlights Strong Capital Position: No Debt, Fully Funded, and Warrants Priced Above Market - ADVFN
PMGC Capital LLC, a Subsidiary of PMGC Holdings Inc. - GlobeNewswire
PMGC Capital Takes 5.09% Stake in Alaunos Therapeutics, Eyes Strategic Changes Including Fintech Expansion - Stock Titan
PMGC Holdings inks employee secondment deal with Northstrive By Investing.com - Investing.com Nigeria
PMGC Holdings inks employee secondment deal with Northstrive - Investing.com
Northstrive Biosciences Signs Binding Term Sheet with - GlobeNewswire
Northstrive Biosciences Signs Binding Term Sheet with Modulant Biosciences for Exclusive Global Animal Health Licensing of EL-22 - Stock Titan
PMGC Holdings Inc. Announces Reverse Stock Split to Maintain Nasdaq Listing Compliance - ADVFN
PMGC Holdings Inc: Navigating Market Fluctuations with a 2.72M Market Cap - investchronicle.com
ELAB’s price-to-free cash flow ratio: How it affects investment decisions - uspostnews.com
PMGC Holdings (ELAB) Continues Uptrend During Pre-Hours On Positive Sentiment - Stocks Telegraph
ELAB Stock Price and Chart — NASDAQ:ELAB - TradingView
RESENDNorthstrive Biosciences Strengthens IP Portfolio with New US Patent Filings for EL-22 and EL-32 Programs Covering Obesity and Animal Health - GlobeNewswire
Northstrive Biosciences Strengthens IP Portfolio with New US Patent Filings for EL-22 and EL-32 Programs Covering Obesity and Animal Health - The Manila Times
Northstrive Biosciences Strengthens IP Portfolio with New - GlobeNewswire
Northstrive Expands Patent Portfolio: New GLP-1 Combo Treatment Could Prevent Muscle Loss in Obesity - Stock Titan
Northstrive Biosciences Co-Founder Featured on Bear Bull Traders Following Announcement of Positive FDA Response Supporting Submission of IND for EL-22 Phase 2 Clinical Trial - The Manila Times
Northstrive Biosciences Co-Founder Featured on Bear Bull - GlobeNewswire
Finanzdaten der Pmgc Holdings Inc-Aktie (ELAB)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.45%
0.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):